Vitamin K2 Bone Density Meta-analysis: What the Evidence Says

Quick Answer

Vitamin K2 Bone Density Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• In the Global Burden of Disease 2019 analysis, low bone mineral density was associated with about 438,000 deaths and 166 million disability-adjusted life years, with large increases since 1990. [Zhang Zechen (2025); evidence level 1]
• In a cross-sectional study of 900 Chinese adults, higher ucOC was associated with lower BMD at the spine, femoral neck, and hip, and with higher P1NP and β-CTX, indicating increased turnover. [Zhang Zechen (2025); evidence level 1]
• Evidence arises simultaneously from metabolic research, neuroendocrinology, hepatology, reproductive biology, and matrix biochemistry, yet these fields differ substantially in experimental models, assay methodologies, isoform definitions, and clinical endpoints. [Derwich Wiktor (2026); evidence level 3]
• This narrative review aims to unify these perspectives by: (a) summarizing structural determinants and carboxylation-dependent isoform biology; (b) outlining receptor-level mechanisms across target organs; (c) consolidating human evidence, including clamp-validated metabolic data; and (d) clarifying methodological and analytical limitations that critically shape the interpretation of OCN physiology. [Derwich Wiktor (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin K2 bone density meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Zhang Zechen (2025). The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis. DOI: 10.3389/fendo.2025.1703116. PMCID: PMC12626859. PMID: 41268154. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12626859/
• Derwich Wiktor (2026). Osteocalcin Beyond Bone: Molecular Mechanisms, Endocrine Networks, and Translational Perspectives Across Metabolism, Neurobiology, and Chronic Disease. DOI: 10.3390/ijms27072992. PMCID: PMC13074106. PMID: 41977179. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13074106/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.